Loading...
Mounting Reimbursement Pressures Will Dampen Traditional Device Outlook
AnalystLowTarget's Fair Value
US$7.00
3.0% overvalued intrinsic discount06 Sep
US$7.21
1Y
-31.3%7D
-2.6%1Y
-31.3%7D
-2.6%Edit anytime before Sep 6 10:11 PM. Then post Updates to your followers.